INSIGHTS ON LIQUID DOSE MANUFACTURING

• 5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes

  In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

• Cost-Effective Strategies For Sterile Injectable Outsourcing

  Explore how CMOs are playing a pivotal role in enabling pharmaceutical companies to optimize their operations and how this collaboration is reshaping the future of pharmaceutical manufacturing.

• The Successful Implementation Of A New Aseptic Filling Line

  Discover how a Quality by Design approach can streamline the development of new sterile product filling lines, featuring a real-life example illustrating its effectiveness.

• From Lipids To Launch: End-To-End Therapy Development

  Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.

• Key Topics And Trends In Aseptic Filling

  1/9/2026

  Aseptic filling is vital yet often guided by outdated practices. Discover expert insights on modern technologies, evolving regulations, and data-driven strategies to improve compliance and reduce risk in this critical manufacturing step.

• Inline Buffer Formulation Systems

  7/6/2026

  Eliminate large storage tanks and optimize cleanroom space with automated inline buffer formulation. See how on-demand fluid handling provides precise, real-time pH and conductivity control.

• Water For Injection: Strategic Utility And The Case For Outsourcing

  3/9/2026

  Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.

• Streamline Global Regulatory Submissions

  5/21/2026

  Discover a more streamlined approach with one accountable partner supporting regulatory submissions globally.

• Rethinking Fill-Finish To Reduce API Loss In Early Development

  6/15/2026

  Early-stage drug programs can preserve constrained API supplies by replacing large-scale manufacturing defaults with deliberate, right-sized fill-finish designs that minimize avoidable process waste.